Ionis Pharmaceuticals, Inc. 0.125% 15-DEC-2024Ionis Pharmaceuticals, Inc. 0.125% 15-DEC-2024Ionis Pharmaceuticals, Inc. 0.125% 15-DEC-2024

Ionis Pharmaceuticals, Inc. 0.125% 15-DEC-2024

No trades
See on Supercharts

Key terms


Outstanding amount
‪44.50 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
0.13% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
0.84%
Maturity date
Dec 15, 2024
Term to maturity
25 days

About Ionis Pharmaceuticals, Inc. 0.125% 15-DEC-2024


Sector
Health Technology
Home page
Issue date
Dec 19, 2019
FIGI
BBG00R3L6254
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.